Increases in nuclear p65 activation in dystrophic skeletal muscle are secondary to increases in the cellular expression of p65 and are not solely produced by increases in IκB-α kinase activity

Journal of the Neurological Sciences

Volumn 285, Issue 1-2, 2009, Pages 159-171

  Singh, Rajvir ^a   Millman, Gregory ^a   Turin, Eric ^a   Polisiakeiwicz, Lucasz ^a   Lee, Brian ^a   Gatti, Francesca ^a   Berge, Jonas ^a   Smith, Emily ^a   Rutter, John ^a   Sumski, Chris ^a   Winders, W Tyler ^a   Samadi, Abbas ^a   Carlson, C George ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

Akt; Becker muscular dystrophy; Cell signaling; Diaphragm; Duchenne muscular dystrophy; Limb musculature; mdx mouse; NF B; Respiratory musculature

Indexed keywords

I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; PROTEIN P100; PROTEIN P50; PROTEIN P52; SUMO 1 PROTEIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; CELL NUCLEUS; CYTOSOL; DIAPHRAGM; FEMALE; I-KAPPA B KINASE; KINETICS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SUMO-1 PROTEIN; TRANSCRIPTION FACTOR RELA;

EID: 69549127944     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.06.030     Document Type: Article

References (68)

1. Luo J.L., Kamata H., and Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 115 10 (2005) 2625-2632
2. Ghosh S., and Hayden M.S. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 11 (2008) 837-848
3. Kim H.J., Hawke N., and Baldwin A.S. NF-kappaB and IKK as therapeutic targets in cancer. Cell Death Differ 13 5 (2006) 738-747
4. Naugler W.E., and Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 189 1 (2008) 19-26
5. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
6. Lee J.H., Song M.Y., Song E.K., Kim E.K., Moon W.S., Han M.K., et al. Overexpression of SIRT1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathway. Diabetes 58 (2009) 344-351
7. Kim S., Millet I., Kim H.S., Kim J.Y., Han M.S., Lee M.K., et al. NF-κB prevents β cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci U S A 104 6 (2007) 1913-1918
8. Okamoto H., Cujec T.P., Yamanaka H., and Kamatani N. Molecular aspects of rheumatoid arthritis: role of transcription factors. FEBS J 275 18 (2008) 4463-4470
9. Simmonds R.E., and Foxwell B.M. Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 47 5 (2008) 584-590
10. Liu S.F., and Malik A.B. NF-κB activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung (Cell Mol Physiol) 290 4 (2006) L622-L645
11. Ahn K.S., and Aggarwal B.B. Transcription factor NF-κB: a sensor for smoke and stress signals. Ann N Y Acad Sci 1056 (2005) 218-233
12. Mroz R.M., Noparlik J., Chyczewska E., Braszko J.J., and Holownia A. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. J Physiol Pharmacol 58 Suppl 5 Pt 2 (2007) 453-460
13. Bulfield G., Siller W.G., Wright W.A.L., and Moore K.J. X-chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci (USA) 81 (1984) 1189-1192
14. Monici M.C., Aguennouz M., Mazzeo A., Messina C., and Vita G. Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 60 (2003) 993-997
15. Kumar A., and Boriek A.M. Mechanical stress activates the nuclear factor-kappa B pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 17 (2003) 386-296
16. Acharyya S., Villalta A., Bakkar N., Bupha-Intr T., Janssen P.M.L., Carathers M., et al. Interplay of IKK/NF-κB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117 (2007) 889-901
17. Tews D.S. Tumour necrosis factor-mediated cell death pathways do not contribute to muscle fibre death in dystrophinopathies. Acta Neuropathol 109 2 (2005) 217-225
18. Macaione V., Aguennouz M., Rodolico C., Mazzeo A., Patti A., Cannistraci E., et al. RAGE-NF-κB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. Acta Neurol Scand 115 2 (2007) 115-121
19. Baghdiguian S., Martin M., Richard I., Pons F., Astier C., Bourg N., et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkBa/NF-kB pathway in limb-girdle muscular dystrophy type 2A. Nat Med 5 (1999) 503-511
20. Hunter R.B., Stevenson E., Koncarevic A., Mitchell-Felton H., Essig D.A., and Kandarian S.C. Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 16 6 (2002) 529-538
21. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., and Baldwin A.S. NF-kB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289 (2000) 2363-2366
22. Cai D., Frantz J.D., Tawa Jr. N.E., Melendez P.A., Oh B.C., Lidov H.G., et al. IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119 2 (2004) 285-298
23. Mourkioti F., Kratsios P., Luedde T., Song Y.H., Delafontaine P., Adami R., et al. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest 116 11 (2006) 2945-2954
24. Chen Y.W., Nagaraju K., Bakay M., McIntyre O., Rawat R., Shi R., et al. Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy. Neurology 65 6 (2005) 826-834
25. Vidal B., Serrano A.L., Tjwa M., Suelves M., Ardite E., De Mori R., et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway. Genes Dev 22 13 (2008) 1747-1752
26. Gosselin L.E., and Williams J.E. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion. Muscle Nerve 33 6 (2006) 820-833
27. Hayakawa M., Miyashita M.H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., Karin M., et al. Evidence that reactive oxygen species do not mediate NF-κB activation. EMBO J 22 (2003) 3356-3366
28. Carlson C.G., Samadi A., and Siegel A. Chronic treatment with agents that stabilize cytosolic IκBα e:nhance survival and improve resting potential in mdx muscle fibers subjected to chronic passive stretch. Neurobiol Dis 20 (2005) 719-730
29. 2+ influx is not increased in a severely dystrophic expiratory muscle (triangularis sterni) of the mdx mouse. Neurobiol Dis 14 2 (2003) 229-239
30. Miura T., Ouchida R., Yoshikawa N., Okamoto K., Makino Y., Nakamura T., et al. Functional modulation of the glucocorticoid receptor and suppression of NF-kB-dependent transcription by ursodeoxycholic acid. J Biol Chem 276 (2001) 47371-47378
31. Siegel A.L., Bledsoe C., Lavin J., Gatti F., Berge J., Millman G., et al. Treatment with inhibitors of the NF-κB pathway improves whole body tension development in the mdx mouse. Neuromuscul Disord 19 (2009) 131-139
32. Messina S., Bitto A., Aguennouz M., Minutoli L., Monici M., Altavilla D., et al. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. Exper Neurol 198 (2006) 234-241
33. Assereto S., Stringara S., Sotgia F., Bonuccelli G., Broccolini A., Pedemonte M., et al. Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment. Am J Physiol (Cell Physiol) 290 2 (2006) C577-C582
34. Thaloor D., Miller K.J., Gephart J., Mitchell P.O., and Pavlath G.K. Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol (Cell Physiol) 277 2 (1999) C320-C329
35. Pan Y., Chen C., Shen Y., Zhu C.H., Wang G., Wang X.C., et al. Curcumin alleviates dystrophic muscle pathology in mdx mice. Mol Cells 25 4 (2008) 531-537
36. Durham W.J., Arbogast S., Gerken E., Li Y.P., and Reid M.B. Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice. Muscle Nerve 34 3 (2006) 298-303
37. Hnia K., Hugon G., Rivier F., Masmoudi A., Mercier J., and Mornet D. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient mdx mice. Am J Pathol 170 2 (2007) 633-643
38. Whitehead N.P., Pham C., Gervasio O.L., and Allen D.G. N-acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 586 7 (2008) 2003-2014
39. Buetler T.M., Renard M., Offord E.A., Schneider H., and Ruegg U.T. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr 75 4 (2002) 749-753
40. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-κB. Annual Rev Cell Biol 10 (1994) 405-455
41. Hayden M.S., and Ghosh S. Shared principles in NF-κB signaling. Cell 32 3 (2008) 344-362
42. Desterro J.M.P., Rodriguez M.P., and Hay R.T. SUMO-1 modification of ΙκBα inhibits NF-κB activation. Mol Cell 2 (1998) 233-239
43. Peter A.K., and Crosbie R. Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway. Exptl Cell Res 312 (2006) 2580-2591
44. Manning B.D., and Cantley L.C. Akt/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
45. Yang L., Dan H.C., Sun M., Liu Q., Sun X.M., Feldman R.I., et al. Akt/Protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 64 (2004) 4394-4399
46. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
47. Ueberla K., Lu Y., Chung E., and Haseltine W.A. The NF-κB p65 promoter. J Acquir Immune Defic Syndr 6 (1993) 227-230
48. Gu L., Findley H.W., and Zhou M. Mdm2 induces NF-κB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of mdm2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood 99 (2002) 3367-3375
49. Visconti R., Cerutti J., Battista S., Fedele M., Trapasso F., Zeki K., et al. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκΒ p65 protein expression. Oncogene 15 (1997) 1987-1994
50. Balcerczak M., Balcerczak E., Walczak P., Kordek R., and Mirowsk M. Expression of the p65 gene in patients with colorectal cancer: comparison with some histological typing, grading and clinical staging. Eur J Surg Oncol 30 3 (2004) 266-270
51. Weichert W., Boehm M., Gekeler V., Bahra M., Langrehr J., Neuhaus P., et al. High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. B J Cancer 97 (2007) 523-530
52. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., and Donner D.B. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401 (1999) 82-85
53. Romashkova J.A., and Makarov S.S. NF-κB is a target of Akt in anti-apoptotic PDGF signaling. Nature 401 (1999) 86-90
54. Gustin J.A., Korgaonkar C.K., Pincheira R., Li Q., and Donner D.B. Akt regulates basal and induced processing of NF-κB2 (p100) to p52. J Biol Chem 281 (2006) 16473-16481
55. Feinstein D.L., Galea E., Aquino D.A., Li G.C., Xu X., and Reis D.J. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NF-κB activation. J Biol Chem 271 30 (1996) 17724-17732
56. Chen H.W., Kuo H.T., Wang S.J., Lu T.S., and Yang R.C. In vivo heat shock protein assembles with septic liver NF-κB/I-κB complex regulating NF-κB activity. Shock 24 3 (2005) 232-238
57. Arthur J.C., Lich J.D., Aziz R.K., Koth M., and Ting J.P.Y. Heat shock protein 90 associates with monarch-1 and regulates its ability to promote degradation of NF-κB-inducing kinase. J Immunol 179 (2007) 6291-6296
58. Ryo A., Suizi F., Yoshida Y., Perrem K., Liou Y.C., Wulf G., et al. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12 (2003) 1413-1426
59. DeTroyer A., Legrand A., Gevenois P.-A., and Wilson T.A. Mechanical advantage of the human parasternal intercostal and triangularis sterni muscles. J Physiol (Lond) 513.3 (1998) 915-925
60. DeTroyer A., and Ninane V. Triangularis sterni: a primary muscle of breathing in the dog. J Appl Physiol 60 (1986) 14-21
61. Ninane V., Baer R.E., and DeTroyer A. Mechanism of triangularis sterni shortening during expiration in dogs. J Appl Physiol 66 5 (1989) 2287-2292
62. Hwang J.C., and Zhou D. St. John WM. Characterization of expiratory intercostal activity to triangularis sterni in cats. J Appl Physiol 67 4 (1989) 1518-1524
63. Ohlendieck K., and Campbell K.P. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115 (1991) 1685-1694
64. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev 18 18 (2004) 2195-2224
65. Deconinck A.E., Rafael J.A., Skinner J.A., Brown S.C., Potter A.C., Metzinger L., et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90 (1997) 717-727
66. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., and Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90 (1997) 729-738
67. Duclos F., Straub V., Moore S.A., Venzke D.P., Hrstka R.F., Crosbie R.H., et al. Progressive muscular dystrophy in alpha sarcoglycan-deficient mice. J Cell Biol 142 (1998) 1461-1471
68. Araishi K., Sasaoka T., Imamura M., Noguch S., Hama H., Wakabayashi E., et al. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in β-sarcoglycan-deficient mice. Hum Mol Genet 8 (1999) 1589-1598